The use of placebo in schizophrenia relapse prevention studies: scientific or ethical debate?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The use of placebo in schizophrenia relapse prevention studies: scientific or ethical debate?

Published:2019-09-18 Issue:4 Volume:140 Page:386-387
ISSN:0001-690X
Container-title:Acta Psychiatrica Scandinavica
language:en
Short-container-title:Acta Psychiatr Scand

Author:

Ćurković Marko¹²^ORCID,Borovečki Ana²³

Affiliation:

1. Department for Diagnostics and Intensive Care University Psychiatric Hospital Vrapče Zagreb Croatia

2. School of Medicine, University of Zagre Zagreb Croatia

3. Department of Social Medicine and Organization of Health Care School of Public Health “Andrija Štampar” Zagreb Croatia

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acps.13085

Reference6 articles.

1. Are placebo‐controlled, relapse prevention trials in schizophrenia research still necessary or ethical?;Lawrence RE;JAMA Psychiatry,2019

2. Discontinuing psychotropic drugs from participants in randomized controlled trials: a systematic review;Cohen D;Psychother Psychosom,2019

3. Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to‐head comparisons;Kishimoto T;World Psychiatry,2019

4. 60 years of placebo‐controlled antipsychotic drug trials in acute Schizophrenia: meta‐regression of predictors of placebo response;Leucth S;Schizophr Res,2018

5. Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs;Kubo K;Acta Psychiatr Scand,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP